상세 보기
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)
- Jo, Jae-Cheol;
- Lee, Ho Sup;
- Suh, Cheolwon;
- Kang, Hye Jin;
- Kim, Won Seog;
- ... Gyeong-Won, Lee;
- 외 9명
Citations
WEB OF SCIENCE
0- 제목
- Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)
- 저자
- Jo, Jae-Cheol; Lee, Ho Sup; Suh, Cheolwon; Kang, Hye Jin; Kim, Won Seog; Eom, HyeonSeok; Kim, Inho; Shin, Ho-Jin; Park, Yong; Lee, Won Sik; Do, Young Rok; Gyeong-Won, Lee; Oh, Sung Yong; Lim, Sung-Nam; Lee, Seong Yoon
- 발행일
- 2019-11-13
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 134
- 언어
- ENG
- 출판사
- American Society of Hematology
- 발행국가
- 미국
- ISSN
- E 1528-0020
P 0006-4971